Growth at Reasonable Price

Results

160

20 new

160 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
INR
US$13.311.8%-7.6%US$864.7mUS$22.635.758.2%n/aEnergy
MDGL
US$543.35-1.8%82.1%US$12.5bUS$679.6411.159.7%n/aPharmaceuticals & Biotech
NVDA
US$208.760.7%20.2%US$5.1tUS$302.8331.722.8%0.5%Semiconductors
SNDX
US$21.21-6.6%112.3%US$2.0bUS$39.458.768.1%n/aPharmaceuticals & Biotech
HIMS
New
US$32.74-2.8%-42.9%US$7.3bUS$29.463.268.5%n/aHealthcare
PICS
US$11.914.5%n/aUS$1.6bUS$20.396.722.8%n/aDiversified Financials
APP
US$398.86-8.2%10.8%US$138.6bUS$654.6034.221.7%n/aSoftware
AVGO
US$392.475.8%35.3%US$1.9tUS$525.4463.733.5%0.7%Semiconductors
ANAB
US$54.911.4%103.4%US$1.6bUS$87.097.048.1%41.0%Pharmaceuticals & Biotech
FPS
US$38.96-1.6%n/aUS$11.8bUS$59.90557.343.4%n/aCapital Goods
ARDX
US$5.13-1.3%19.6%US$1.3bUS$16.303.056.0%n/aPharmaceuticals & Biotech
AGBK
US$6.69-4.7%n/aUS$1.1bUS$13.981.228.7%n/aBanks
EROC
US$11.9317.5%n/aUS$3.4bUS$22.633.056.3%n/aCapital Goods
TYGO
US$1.771.7%36.9%US$136.6mUS$6.8539.943.3%n/aCapital Goods
WBI
US$35.541.9%n/aUS$4.5bUS$34.432.777.2%0.6%Energy
ALHC
US$20.00-0.1%71.8%US$4.3bUS$24.92208.839.5%n/aHealthcare
IONS
US$55.872.7%32.3%US$9.2bUS$92.008.761.0%n/aPharmaceuticals & Biotech
ORCL
US$120.04-3.4%-50.6%US$362.5bUS$248.1520.424.2%1.7%Software
FLEX
New
US$127.945.6%157.6%US$46.5bUS$170.7053.337.8%n/aTech
BMRC
US$28.29-3.9%17.8%US$455.0mUS$29.201.1109.0%3.5%Banks
CAPR
US$19.833.7%206.0%US$1.1bUS$53.604.164.2%n/aPharmaceuticals & Biotech
PTHS
US$28.406.3%29.1%US$92.0mUS$57.713.665.9%n/aPharmaceuticals & Biotech
LKNC.Y
US$32.030.3%-13.1%US$10.4bUS$45.7119.622.1%n/aConsumer Services
ABEO
US$6.38-9.1%-4.1%US$365.9mUS$19.715.532.9%n/aPharmaceuticals & Biotech
Page 1 of 5